Literature DB >> 7726619

The use of haemopoietic growth factors in blood disorders.

I M Hann1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7726619      PMCID： PMC1030097          DOI： 10.1136/adc.71.6.543

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  34 in total

1.  Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor: a preliminary report.

Authors:  Y Kobayashi; T Okabe; K Ozawa; S Chiba; M Hino; K Miyazono; A Urabe; F Takaku
Journal:  Am J Med       Date:  1989-02       Impact factor: 4.965

2.  Cloning and expression of the human erythropoietin gene.

Authors:  F K Lin; S Suggs; C H Lin; J K Browne; R Smalling; J C Egrie; K K Chen; G M Fox; F Martin; Z Stabinsky
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

3.  Congenital agranulocytosis terminating in acute myelomonocytic leukemia.

Authors:  R B Rosen; S J Kang
Journal:  J Pediatr       Date:  1979-03       Impact factor: 4.406

4.  Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia.

Authors:  K Welte; C Zeidler; A Reiter; W Müller; E Odenwald; L Souza; H Riehm
Journal:  Blood       Date:  1990-03-01       Impact factor: 22.113

5.  A radioimmunoassay for erythropoietin.

Authors:  J B Sherwood; E Goldwasser
Journal:  Blood       Date:  1979-10       Impact factor: 22.113

6.  Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy.

Authors:  L T Goodnough; S Rudnick; T H Price; S K Ballas; M L Collins; J P Crowley; M Kosmin; M S Kruskall; B A Lenes; J E Menitove
Journal:  N Engl J Med       Date:  1989-10-26       Impact factor: 91.245

7.  Recombinant human erythropoietin for patients with AIDS treated with zidovudine.

Authors:  M Fischl; J E Galpin; J D Levine; J E Groopman; D H Henry; P Kennedy; S Miles; W Robbins; B Starrett; R Zalusky
Journal:  N Engl J Med       Date:  1990-05-24       Impact factor: 91.245

8.  Correction of infantile agranulocytosis (Kostmann's syndrome) by allogeneic bone marrow transplantation.

Authors:  J M Rappeport; R Parkman; P Newburger; B M Camitta; M J Chusid
Journal:  Am J Med       Date:  1980-04       Impact factor: 4.965

9.  Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes.

Authors:  S Vadhan-Raj; M Keating; A LeMaistre; W N Hittelman; K McCredie; J M Trujillo; H E Broxmeyer; C Henney; J U Gutterman
Journal:  N Engl J Med       Date:  1987-12-17       Impact factor: 91.245

10.  Bone marrow transplantation for constitutional pure red cell aplasia.

Authors:  C Lenarsky; K Weinberg; E Guinan; P P Dukes; Y Barak; J Ortega; S Siegel; K Williams; J Lazerson; H Weinstein
Journal:  Blood       Date:  1988-01       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.